Colin Hayward joins Premier Research as European medical director
This article was originally published in Scrip
Premier Research, a services company providing clinical development support to the pharmaceutical, biotech and medical device industries, has appointed Dr Colin Hayward European medical director. In this position, Dr Hayward will be responsible for leading and developing the company's European medical affairs and pharmacovigilance operations. Dr Hayward is a pharmaceutical physician, and most recently served as director of Prism Ideas. He has 12 years' international experience in pharmacovigilance, design and implementation of clinical programmes and medical affairs, including several positions at Roche.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.